Moneycontrol PRO
Open App

Zydus Lifesciences: Nephrology, biosimilar scope takes focus

Valuation reasonable on the back of traction in branded business

August 12, 2022 / 08:49 AM IST
Zydus Lifesciences: Nephrology, biosimilar scope takes focus

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Zydus Lifesciences: (CMP: Rs 365, Market Cap: Rs 37,321 crore) has posted a sequential improvement in quarterly performance, led by the US, EM (emerging markets), and the consumer wellness segment though it was offset by the softness in the domestic formulation business. The domestic formulation business (29 percent of sales) declined by 3.3 percent sequentially. On a year-on-year (YoY) basis, the decline was 17 percent on a high base of COVID-related sales (Remdesivir etc) in the previous period. Ex-COVID, the...

  • PRO Panorama

    Moneycontrol Pro Panorama | Markets weigh outlook on consumption and investment

    Oct 4, 2022 / 03:10 PM IST

    In today’s edition of Moneycontrol Pro Panorama: Warning signs from European currency market, India's healthcare sector needs regulation, surge in real estate sector, Bosch promises new growth avenues, and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | Fighting the Fed 

    Sep 3, 2022 / 10:06 AM IST

    India is bracing for the ripple effect of the frontloading of rate hikes by the US Fed. The question is, can it have the last laugh

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers